Ipride Sr (150mg) 20 Capsules
Metformin sustained-release 150mg for type 2 diabetes.
Ipride Sr (150mg) contains metformin in sustained-release formulation for type 2 diabetes. It reduces hepatic glucose output and improves insulin sensitivity. The 150mg strength may be a lower dose; typical SR doses are 500–2000mg daily. Take as directed with meals.
Purpose
Treatment of type 2 diabetes mellitus as adjunct to diet and exercise.
Ingredients
Metformin hydrochloride 150mg (sustained-release) per capsule.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Not for type 1 diabetes. Risk of lactic acidosis.
Side Effects
Nausea, diarrhoea, abdominal discomfort, metallic taste. Rare: lactic acidosis. Report unexplained muscle pain or breathing difficulty.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | Wilshire Labs (PVT.) LTD. |
| Status | Active |
Related Products
